206 related articles for article (PubMed ID: 25327563)
21. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
[TBL] [Abstract][Full Text] [Related]
22. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
24. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
25. CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche.
Roy L; Bobbs A; Sattler R; Kurkewich JL; Dausinas PB; Nallathamby P; Cowden Dahl KD
Cancer Growth Metastasis; 2018; 11():1179064418767882. PubMed ID: 29662326
[TBL] [Abstract][Full Text] [Related]
26. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
27. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.
Liao J; Qian F; Tchabo N; Mhawech-Fauceglia P; Beck A; Qian Z; Wang X; Huss WJ; Lele SB; Morrison CD; Odunsi K
PLoS One; 2014; 9(1):e84941. PubMed ID: 24409314
[TBL] [Abstract][Full Text] [Related]
29. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
[TBL] [Abstract][Full Text] [Related]
30. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
31. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
32. Characterization of primary ovarian cancer cells in different culture systems.
Liu T; Cheng W; Lai D; Huang Y; Guo L
Oncol Rep; 2010 May; 23(5):1277-84. PubMed ID: 20372841
[TBL] [Abstract][Full Text] [Related]
33. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
Guo R; Wu Q; Liu F; Wang Y
Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
[TBL] [Abstract][Full Text] [Related]
34. LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells.
Chen X; Wei B; Han X; Zheng Z; Huang J; Liu J; Huang Y; Wei H
Int J Mol Med; 2014 Jul; 34(1):35-42. PubMed ID: 24789370
[TBL] [Abstract][Full Text] [Related]
35. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
36. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.
Cioffi M; D'Alterio C; Camerlingo R; Tirino V; Consales C; Riccio A; Ieranò C; Cecere SC; Losito NS; Greggi S; Pignata S; Pirozzi G; Scala S
Sci Rep; 2015 May; 5():10357. PubMed ID: 26020117
[TBL] [Abstract][Full Text] [Related]
37. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
[TBL] [Abstract][Full Text] [Related]
38. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
Yin BB; Wu SJ; Zong HJ; Ma BJ; Cai D
J Zhejiang Univ Sci B; 2011 Apr; 12(4):256-63. PubMed ID: 21462380
[TBL] [Abstract][Full Text] [Related]
39. ARID3B Directly Regulates Ovarian Cancer Promoting Genes.
Bobbs A; Gellerman K; Hallas WM; Joseph S; Yang C; Kurkewich J; Cowden Dahl KD
PLoS One; 2015; 10(6):e0131961. PubMed ID: 26121572
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
